Release Date: 23/10/12 09:19 Summary: Renouncable Rights Offer Completed Price Sensitive: No Download Document 119.84KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%